Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

MEDIFAST INC

Medipharm Labs (Otc) (($TSE:LABS)) has held its Q4 earnings call. Read on for the main highlights of the call. Medipharm Labs’ latest earnings call...

Medipharm Labs Earnings Call Highlights Global Growth Pivot

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medios AG (MEDOF), Regeneron (REGN) and Siemens Heal...

Wall Street Analysts Are Bullish on Top Healthcare Picks

MediPharm Labs ( ($TSE:LABS) ) just unveiled an update. MediPharm Labs reported 2025 revenue of $45.1 million, up 8% year over year, with internati...

MediPharm Labs Boosts International Medical Cannabis Revenue and Tightens Costs in 2025

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hyperion DeFi (HYPD), Kyverna Therapeutics, Inc. (KY...

Analysts Offer Insights on Healthcare Companies: Hyperion DeFi (HYPD), Kyverna Therapeutics, Inc. (KYTX) and Medios AG (OtherMEDOF)

MediPharm Labs ( ($TSE:LABS) ) has provided an announcement. MediPharm Labs, a specialized pharmaceutical cannabis company focused on precision-bas...

MediPharm Labs Sets March 30 Date for 2025 Results and Investor Call

In a report released today, Tanya Hansalik from UBS maintained a Hold rating on Medartis Holding AG, with a price target of CHF87.00. Hansalik cove...

UBS Keeps Their Hold Rating on Medartis Holding AG (MED)

Globus Medical ( ($GMED) ) has issued an announcement. On March 23, 2026, Globus Medical announced that board member John A. DeFord, Ph.D., resigne...

Globus Medical Announces Board Resignation, Affirms Governance Stability

Medaro Mining ( ($TSE:MEDA) ) has shared an update. Medaro Mining has launched a geological exploration program at its Bastnäs project in Sweden, t...

Medaro Mining Begins Exploration Program at Bastnäs Rare Earths Project in Sweden

In a report released today, Tanya Hansalik from UBS maintained a Hold rating on Medartis Holding AG, with a price target of CHF92.00. Hansalik cove...

UBS Reaffirms Their Hold Rating on Medartis Holding AG (MED)

The latest announcement is out from Medaro Mining ( ($TSE:MEDA) ). Medaro Mining has launched a geological exploration program at its Bastnäs proje...

Medaro Mining Launches Exploration Program at Swedish Bastnäs Critical Minerals Project

Medacta Group SA ( ($CH:MOVE) ) has provided an update. Medacta Group SA, a Swiss orthopaedics manufacturer listed on SIX under the ticker MOVE, de...

Medacta Delivers Record 2025 Results and Lifts Growth Targets on Broad-Based Orthopaedics Momentum

Medaro Mining ( ($TSE:MEDA) ) has provided an announcement. Medaro Mining has secured exploration permits for its Bastnäs project in Sweden’s Skinn...

Medaro Mining Secures Key Exploration Permits for Swedish Bastnäs Project

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medpace Holdings (MEDP – Research Report), Revolutio...

Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP), Revolution Medicines (RVMD) and Corbus Pharmaceuticals (CRBP)

Berenberg Bank analyst Sam England maintained a Buy rating on Medios AG yesterday and set a price target of €27.00. The company’s shares closed las...

Berenberg Bank Reaffirms Their Buy Rating on Medios AG (MEDOF)

In a report released on March 6, Luigi Tramontana from Kepler Capital maintained a Hold rating on Banca Mediolanum SpA, with a price target of €21....

Banca Mediolanum SpA (BNMDF) Gets a Hold from Kepler Capital

In a report released on March 6, Nicolas Pauillac from Kepler Capital maintained a Buy rating on MedinCell SA, with a price target of €36.60. The c...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MED	$10.49	+1.25%	126.42K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MED	$10.49	+1.3%	126.42K
3
4
5
6

MED

MED

Get MEDIFAST INC Data in Excel

Get MEDIFAST INC Data in Excel